What is Chelko?
Chelko Consulting Group operates as a specialized consultancy dedicated to optimizing health benefits for large plan sponsors. By eschewing traditional commission-driven models, the firm eliminates inherent conflicts of interest, ensuring that its strategic advice remains strictly aligned with client objectives. Their core competencies include comprehensive data analysis, vendor selection, and the implementation of value-based drug management programs. By focusing on the mitigation of waste in medical and pharmaceutical benefit structures, Chelko provides a high-utility service that directly impacts the bottom line of its corporate clients while simultaneously enhancing the quality of member experiences.
How much funding has Chelko raised?
Chelko has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Chelko
PPP
Public-Private Partnership
What's next for Chelko?
With this late-stage capital injection, Chelko is well-positioned to scale its proprietary consulting methodologies and broaden its reach among enterprise-level organizations. The firm is expected to leverage these resources to enhance its analytical reporting capabilities and further refine its value-based drug management frameworks. As the healthcare sector continues to grapple with rising costs and administrative complexity, Chelko's commitment to transparency and cost-efficiency provides a distinct competitive advantage. Future growth will likely focus on deepening market penetration and investing in the technological infrastructure required to support increasingly complex plan administration needs, ensuring the firm remains a leader in the health benefits consulting space.
See full Chelko company page
